Blog
Keep up with the latest healthcare AI insights from our expert team of artificial intelligence and machine learning gurus in our blog.
Foundations of AI for Early Detection of Lung Cancer: The Data Fueling AI Models
Explore AI's promise in early lung cancer detection through insights from experts at Lucem Health and Medial EarlySign, addressing challenges and strategies.
Treating Liver Disease: A Look at the Underlying AI Model for Early Detection
Unlocking new possibilities in treating liver disease with Lucem Health's Reveal, an AI-driven tool for efficient and early detection.
Advancements in Liver Disease Treatment: Spotlight on MASLD and MASH
Discover how recent developments in liver disease treatment are offering new therapeutic options and reshaping patient care.
FIB-4 Score: Exploring Current Limitations & Improvement Opportunities
The role of the FIB-4 score in liver disease management, its limitations, plus alternative diagnostic approaches for better outcomes.
The Economic Benefits of Detecting Liver Disease Early
A look at how early detection of liver disease can significantly decrease costs while enhancing care quality and outcomes.
NAFLD Guidelines: A Shift in Understanding & Focus
Exploring the recent shift in NAFLD guidelines and why redefining the condition as MASLD has broader implications for providers and patients.
Diagnosing MASH (Liver Disease): A Meaningful Opportunity for Early Detection
Learn why addressing MASH, liver disease in an earlier stage, is crucial for improving patient outcomes and reducing healthcare costs.
Patient Throughput & Early Disease Detection: Perspectives from Lisa Meyer
Lisa Meyer MSN, RN, NI-BC, shares insights on improving patient throughput, tackling capacity challenges with early detection, and more.
Strategies for Increasing Patient & Provider Engagement with Early Detection: Q&A with Raghu Pillai
Raghu Pillai shares how early disease detection impacts patient and provider engagement, plus insights on personalized care strategies.
